Ligand validation:4P02

PLC: DIUNDECYL PHOSPHATIDYL CHOLINE

PLC is a Ligand Of Interest in 4P02 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4P02_PLC_B_802	10%	82%	0.251	0.892	0.26	0.54	-	-	0	0	26%	0.2619
4P02_PLC_B_803	10%	84%	0.201	0.844	0.25	0.5	-	-	0	0	21%	0.2143
4P02_PLC_A_920	8%	43%	0.377	0.874	1.12	1.1	2	3	0	0	90%	0.9048
4P02_PLC_B_804	5%	82%	0.37	0.911	0.25	0.54	-	-	0	0	26%	0.2619
4P00_PLC_A_922	12%	42%	0.283	0.836	1.12	1.12	2	3	1	0	90%	0.9048
5EJZ_PLC_B_803	10%	72%	0.261	0.91	0.3	0.77	-	-	1	0	21%	0.2143
5EIY_PLC_A_901	4%	45%	0.421	0.822	1.11	1.03	4	2	0	0	90%	0.9048
4DOS_PLC_A_603	64%	52%	0.134	0.933	0.97	0.88	2	-	1	0	100%	0.869
3UUB_PLC_F_320	16%	88%	0.19	0.908	0.45	0.22	-	-	0	0	17%	16.669999999999998
6HZ1_PLC_E_401	12%	95%	0.233	0.842	0.19	0.2	-	-	0	0	57%	0.5714

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.